fenton's reagent has been researched along with bufexamac in 1 studies
| Studies (fenton's reagent) | Trials (fenton's reagent) | Recent Studies (post-2010) (fenton's reagent) | Studies (bufexamac) | Trials (bufexamac) | Recent Studies (post-2010) (bufexamac) |
|---|---|---|---|---|---|
| 1,891 | 1 | 843 | 111 | 15 | 31 |
| Protein | Taxonomy | fenton's reagent (IC50) | bufexamac (IC50) |
|---|---|---|---|
| leucine aminopeptidase | Homo sapiens (human) | 0.31 | |
| M17 leucyl aminopeptidase | Plasmodium falciparum 3D7 | 0.41 | |
| M18 aspartyl aminopeptidase | Plasmodium falciparum 3D7 | 10.02 | |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | 13.97 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 0.1288 | |
| M17 leucyl aminopeptidase | Plasmodium falciparum 3D7 | 1 | |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | 81.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neubert, RH; Plätzer, M; Podhaisky, HP; Raith, K; Trommer, H; Wohlrab, W | 1 |
1 other study(ies) available for fenton's reagent and bufexamac
| Article | Year |
|---|---|
Examinations of the antioxidative properties of the topically administered drug bufexamac reveal new insights into its mechanism of action.
Topics: Administration, Topical; alpha-Linolenic Acid; Anti-Inflammatory Agents; Antioxidants; Bufexamac; Cell Culture Techniques; Free Radicals; Humans; Hydrogen Peroxide; Hydroxyl Radical; Iron; Keratinocytes; Lipid Peroxidation; Mass Spectrometry; Oxidants; Ultraviolet Rays | 2003 |